The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability

Brivaracetam (BRV) is recognized as a novel third-generation antiepileptic drug approved for the treatment of epilepsy. Emerging evidence has demonstrated that it has potentially better efficacy and tolerability than its analog, Levetiracetam (LEV). This, however, cannot be explained by their common...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Te-Yu Hung, Sheng-Nan Wu, Chin-Wei Huang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2021-04-01
סדרה:	Biomedicines
נושאים:	brivaracetam M-type K<sup>+</sup> current voltage-gated Na<sup>+</sup> current large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel neuron seizure
גישה מקוונת:	https://www.mdpi.com/2227-9059/9/4/369
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!